Literature DB >> 19330338

[Dermatomyositis].

G Stoltenburg-Didinger1, E Genth.   

Abstract

Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (elevated serum CK, myoglobinuria) may be initially absent. Magnetic resonance tomography frequently shows edema of the involved muscles, while electromyography shows a myopathic pattern with spontaneous activity. Muscle biopsy from involved muscle with histological, immunohistological, histochemical and possibly electron-microscopic examination confirms the diagnosis of inflammatory muscle disease and furthermore of DM-specific muscular findings. Typical findings include the deposition of 5b-9 complement components (membrane attack complex) at the capillaries, perifascicular inflammatory infiltrates composed predominantly of CD4+ T-lymphocytes, B-lymphocytes and plasmacytoid dendritic cells, endothelial swelling and damage, loss of capillaries with perifascicular atrophy and tubuloreticular endothelial inclusions on electron-microscopic examination. Detection of myositis-specific autoantibodies is especially helpful in the diagnosis of early and atypical cases with features of overlapping disease.

Entities:  

Mesh:

Year:  2009        PMID: 19330338     DOI: 10.1007/s00393-008-0398-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Tubuloreticular structures in different types of myositis: implications for pathogenesis.

Authors:  Irene M Bronner; Jessica E Hoogendijk; Henk Veldman; Marja Ramkema; Marius A van den Bergh Weerman; Annemieke J M Rozemuller; Marianne de Visser
Journal:  Ultrastruct Pathol       Date:  2008 Jul-Aug       Impact factor: 1.094

3.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

Review 4.  Myositis: an update on pathogenesis.

Authors:  Lisa Christopher-Stine; Paul H Plotz
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

Review 5.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

Review 6.  A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Authors:  Pedram Gerami; Jennifer M Schope; Lauren McDonald; Hobart W Walling; Richard D Sontheimer
Journal:  J Am Acad Dermatol       Date:  2006-01-23       Impact factor: 11.527

7.  The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis.

Authors:  A N Crowson; C M Magro
Journal:  Hum Pathol       Date:  1996-01       Impact factor: 3.466

8.  Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.

Authors:  Maryam Fathi; Jenny Vikgren; Marianne Boijsen; Ulf Tylen; Lennart Jorfeldt; Göran Tornling; Ingrid E Lundberg
Journal:  Arthritis Rheum       Date:  2008-05-15

9.  Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene.

Authors:  K G Claeys; M Fardeau; R Schröder; T Suominen; K Tolksdorf; A Behin; O Dubourg; B Eymard; T Maisonobe; T Stojkovic; G Faulkner; P Richard; P Vicart; B Udd; T Voit; G Stoltenburg
Journal:  Neuromuscul Disord       Date:  2008-07-23       Impact factor: 4.296

Review 10.  Developments in the scientific and clinical understanding of inflammatory myopathies.

Authors:  Ingrid E Lundberg; Cecilia Grundtman
Journal:  Arthritis Res Ther       Date:  2008-10-10       Impact factor: 5.156

View more
  2 in total

Review 1.  [Is bioptic assurance reasonable in patients with Sjögren's syndrome? From focus score to diagnosing vasculitides].

Authors:  V Krenn; M Jakobs; J Kriegsmann; M G Krukemeyer; A Rieger
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

2.  [Severe dysphagia and erythrodermia in a 59-year-old man].

Authors:  M A Zuber; M Kouba; S E Rudolph; M Weller; P Hrdlicka
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.